Article Information
vol. 70 no. 5 1316-1319
PubMed
Print ISSN
Online ISSN
History
- Accepted April 1, 2022
- Published online June 22, 2022.
Copyright & Usage
© American Federation for Medical Research 2022. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Author Information
- 1 Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
- 2 The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, Texas, USA
- Correspondence to Dr Modupe Idowu, Department of Internal Medicine, The University of Texas Health Science Center at Houston, John P and Katherine G McGovern Medical School, Houston, TX 77030, USA; modupe.idowu{at}uth.tmc.edu
Article usage
Statistics from Altmetric.com
Vol 70 Issue 5
Table of Contents
Patient perception of voxelotor treatment benefit in sickle cell disease
Respond to this article